Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group has completed a Hong Kong IPO, raising a total of US$764 million by selling 999.6 million shares at HK$5.92 per share, according to an official announcement. The final IPO size is largely inline with previous estimates when the company was reported to plan for a US$750 million […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network